Literature DB >> 2087875

Comparison of lung histopathology and bronchoalveolar lavage cytology in mice and cotton rats infected with respiratory syncytial virus.

F Vaux-Peretz1, B Meignier.   

Abstract

Lung histology as well as cell number and size distribution in bronchoalveolar lavage (BAL) were compared in Balb/c mice and in cotton rats, of various immune status regarding the respiratory syncytial virus (RSV), when subjected to challenge with RSV. In mock-immunized animals, RSV infection typically caused microscopic inflammatory lesions of the lungs and the presence of inflammatory cells in the BAL. Immunization with a formalin inactivated vaccine prior to challenge increased the severity of the lung lesions and the number of cells recovered in the BAL. We observed that cotton rats are more convenient to study primary RSV infections, inasmuch naive subjects show more pronounced lesions than do naive mice. Conversely, the changes in lung histopathology and in BAL cytology associated with exposure to formalin inactivated vaccine prior to challenge were more apparent in mice, making them a more suitable model for potentiation studies. Moreover, mice showed less individual fluctuations than cotton rats. The reading of the lung sections could be made less tedious by use of computer image analysis, which results paralleled those of conventional examination. In mice, cytological analysis of the BAL could be used in place of lung histology for some potentiation studies since the number of cells recovered in BAL reflected the intensity of the lung lesions and size distribution profiles typical of potentiation were recognized.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2087875     DOI: 10.1016/0264-410x(90)90005-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Autocrine regulation of interleukin-8 by interleukin-1alpha in respiratory syncytial virus-infected pulmonary epithelial cells in vitro.

Authors:  J A Patel; Z Jiang; N Nakajima; M Kunimoto
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

2.  Characterization of Cotton Rat (Sigmodon hispidus) Eosinophils, Including Their Response to Respiratory Syncytial Virus Infection.

Authors:  M Gia Green; Natasha Petroff; Krista M D La Perle; Stefan Niewiesk
Journal:  Comp Med       Date:  2018-02-01       Impact factor: 0.982

3.  Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV.

Authors:  M E Waris; C Tsou; D D Erdman; D B Day; L J Anderson
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

4.  Use of a highly sensitive strand-specific quantitative PCR to identify abortive replication in the mouse model of respiratory syncytial virus disease.

Authors:  Richard Bannister; Deborah Rodrigues; Edward J Murray; Carl Laxton; Mike Westby; Helen Bright
Journal:  Virol J       Date:  2010-09-22       Impact factor: 4.099

5.  Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.

Authors:  Hoyin Mok; Sujin Lee; Thomas J Utley; Bryan E Shepherd; Vasiliy V Polosukhin; Martha L Collier; Nancy L Davis; Robert E Johnston; James E Crowe
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

6.  Targeting Host Cell Surface Nucleolin for RSV Therapy: Challenges and Opportunities.

Authors:  Peter Mastrangelo; Michael J Norris; Wenming Duan; Edward G Barrett; Theo J Moraes; Richard G Hegele
Journal:  Vaccines (Basel)       Date:  2017-09-19

Review 7.  The CD4 T cell response to respiratory syncytial virus infection.

Authors:  Allison F Christiaansen; Cory J Knudson; Kayla A Weiss; Steven M Varga
Journal:  Immunol Res       Date:  2014-08       Impact factor: 4.505

8.  Distinct types of lung disease caused by functional subsets of antiviral T cells.

Authors:  W H Alwan; W J Kozlowska; P J Openshaw
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.